Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Sci Signal. 2016 Aug 23;9(442):ra83. doi: 10.1126/scisignal.aaf5642

Table 1.

Passive membrane properties of the analyzed neurons exposed to various treatments.

Figure Treatment n Vm (mV) Rinput (megohms) τ(ms) Cm (pF)
1 CTL 16 −57.6 ± 1.1 570 ± 39 62.7 ± 4.7 58.3 ± 2.6
RG108 16 −62.1 ± 1.7* 575 ± 52 63.6 ± 5.9 66.7 ± 5.6
2 CTL 7 −60.1 ± 1.3 606 ± 75 63.3 ± 5.6 65.7 ± 4.4
RG108 + APV 5 −60.4 ± 3.2 478 ± 80 66.4 ± 6.7 67.2 ± 8.3
RG108 + NBQX + APV 7 −58.4 ± 2.1 527 ± 50 67.9 ± 7.4 69.2 ± 6.3
RG108 + TTX 7 −58.7 ± 1.9 590 ± 96 77.9 ± 13.4 58.2 ± 5.8
3 CTL 11 −59.3 ± 1.2 589 ± 59 61.1 ± 4.7 60.9 ± 3.6
RG108 + ActD 4 −59.3 ± 4.1 579 ± 153 64.1 ± 10.6 46.3 ± 2.0
Scrambled CTL 6 −57.3 ± 1.5 594 ± 30 62.6 ± 4.1 67.0 ± 5.4
Tet1 ASO + RG108 7 −61.0 ± 1.7 619 ± 121 60.8 ± 5.2 52.7 ± 7.2
5 CTL 10 −59.0 ± 1.3 621 ± 53 62.2 ± 4.7 55.6 ± 5.1
RG108 13 −62.6 ± 1.2 599 ± 59 62.9 ± 6.1 60.7 ± 3.7
6 (A to E) Scrambled CTL 12 −56.8 ± 1.1 516 ± 32 59.5 ± 3.9 55.5 ± 4.2
Dnmt1 ASO 9 −58.9 ± 1.2 613 ± 83 61.0 ± 4.6 56.9 ± 7.4
Dnmt3a ASO 7 −60.7 ± 2.0 626 ± 61 66.6 ± 7.2 50.4 ± 3.5
6 (F to H) Scrambled CTL 8 −57.0 ± 1.0 541 ± 35 56.8 ± 4.1 60.8 ± 4.8
Dnmt1 ASO 5 −58.4 ± 2.0 507 ± 22 55.0 ± 4.5 65.4 ± 11.6
Dnmt3a ASO 5 −63.4 ± 2.0 670 ± 71 70.3 ± 9.3 55.2 ± 8.1
7 (A and B, and E and F) CTL 8 −56.4 ± 1.0 634 ± 54 63.0 ± 5.8 50.4 ± 5.0
CTL + apamin 5 −58.4 ± 3.0 704 ± 41 73.3 ± 4.3 54.9 ± 5.3
RG108 10 −62.0 ± 1.4 610 ± 68 61.6 ± 6.5 56.5 ± 2.8
RG108 + apamin 4 −59.8 ± 4.0 683 ± 110 67.8 ± 5.7 58.1 ± 4.0
7 (C and D, and G and H) CTL 18 −58.1 ± 1.1 570 ± 38 62.3 ± 4.2 60.3 ± 2.7
CTL + apamin 5 −58.4 ± 3.0 704 ± 41 73.3 ± 4.3 54.9 ± 5.3
RG108 19 −62.7 ± 1.5 575 ± 48 63.5 ± 5.4 67.1 ± 5.1
RG108 + apamin 4 −59.8 ± 4.0 683 ± 110 67.8 ± 5.7 58.1 ± 4.0

All values are means ± SEM.

*

P < 0.05, Student’ t test. n, number of cells; Vm, resting membrane potential; Rinput, input resistance; τ, membrane time constant; Cm, membrane capacitance; ActD, actinomycin D.